< Return to Video

2nd Generation Antipsychotics (Psychiatry) (Pharmacology) - USMLE Step 1

  • 0:00 - 0:03
    Welcome back to Mad Medicine.
  • 0:03 - 0:06
    In this lecture, we're gonna be discussing the second generation antipsychotics.
  • 0:06 - 0:09
    If you guys don't know, we have already covered the first gen antipsychotics in our
  • 0:09 - 0:13
    previous lecture, so you can go to our YouTube channel, youtube.com/madmedicine,
  • 0:13 - 0:19
    where you can find playlist for the USMLE Step One, both psychiatry and pharmacology.
  • 0:19 - 0:24
    And in those playlists, we have discussed the first generation or the typical antipsychotic.
  • 0:24 - 0:27
    So I highly recommend you check that out.
  • 0:27 - 0:30
    And don't forget to like, comment, and subscribe to our channel because
  • 0:30 - 0:34
    we're gonna be posting brand new videos for step one regularly.
  • 0:34 - 0:37
    So let's talk about these second gen antipsychotics,
  • 0:37 - 0:40
    AKA the atypical antipsychotics.
  • 0:40 - 0:44
    There are several that you need to know, but luckily, there is a very easy way of remembering
  • 0:44 - 0:49
    these drugs. Okay. So the first drug that you need to know is called aripiprazole.
  • 0:49 - 0:52
    And this one really isn't gonna conform to any
  • 0:52 - 0:55
    suffix pattern, but you just need to memorize aripiprazole.
  • 0:55 - 0:59
    And now the rest of the drugs are gonna
    fall into one of two patterns. Right?
  • 0:59 - 1:03
    So the first pattern is gonna have a suffix of
  • 1:03 - 1:07
    a p I n e, the apines, which is
  • 1:07 - 1:14
    these drugs right here, which are these drugs, like clozapine, olanzapine, quetopine, and acinepine.
  • 1:14 - 1:17
    So these are gonna be your apine antipsychotics.
  • 1:17 - 1:23
    And then the last one are gonna be the i d o n e, idone antipsychotics
  • 1:23 - 1:26
    like illoperidone, paliperidone, risperidone,
  • 1:26 - 1:29
    lurasidone, and zeprazodone.
  • 1:29 - 1:33
    So these are gonna be all of your antipsychotics. So I highly recommend, for second
  • 1:33 - 1:37
    gen, you memorize the apine, the idone suffixes,
  • 1:37 - 1:43
    and then just memorize aripiprazole and you'll be able to spot any of these drugs very easily.
  • 1:43 - 1:46
    Now, when it comes to SGAs, these are gonna be able to treat
  • 1:46 - 1:49
    everything in FGA, the first gen antipsychotics treat
  • 1:49 - 1:52
    with the exception of schizophrenia.
  • 1:52 - 1:56
    First gen antipsychotics only treated- let's just write this down. First gen antipsychotics
  • 1:57 - 2:02
    only treated the positive symptoms of schizophrenia.
  • 2:02 - 2:06
    Okay? Schizophrenia.
  • 2:06 - 2:10
    Let's write this. Alright. When it comes to second gen antipsychotics, you're gonna treat both
  • 2:10 - 2:15
    the positive and the negative symptoms. So therefore, in theory, this is a much better
  • 2:15 - 2:18
    drug to use for treating treatment of schizophrenia, not just for this
  • 2:18 - 2:21
    reason, but for also the other side effect reasons that we're
  • 2:21 - 2:24
    gonna talk about in a second. And you can also use this for OCD.
  • 2:24 - 2:28
    So that's one main difference between first gen and second gen. It's gonna be the positive and
  • 2:28 - 2:33
    negative symptom treatment for schizophrenia. You can also use these for bipolar disorder, delirium,
  • 2:33 - 2:36
    Tourette's and Huntington's and psychosis, kinda like the
  • 2:36 - 2:40
    same as the first gen. Now one defining feature, and this is
  • 2:40 - 2:45
    very important, the defining feature between first generation and second generation antipsychotics
  • 2:45 - 2:49
    is gonna be decreased, EPS or the neurologic symptoms
  • 2:49 - 2:54
    that occur with the high potency first gen antipsychotics.
  • 2:54 - 2:59
    Okay? This is very high yield. High yield is fuck in my opinion because you
  • 2:59 - 3:03
    can be tested on what the defining feature between these two drug classes is and
  • 3:03 - 3:07
    it's the fact that you have less neurologic symptoms occurring with the second gen.
  • 3:07 - 3:12
    Now, when it comes to mechanism of action, we do not know exactly
  • 3:12 - 3:17
    what's happening with second generation antipsychotics. What we do know is that you have the
  • 3:17 - 3:21
    blockade of the postsynaptic d two receptors that also occurs
  • 3:21 - 3:25
    in, first generation antipsychotics.
  • 3:25 - 3:28
    Okay, also have this. So it's the same mechanism.
  • 3:28 - 3:31
    So just to review, if you guys have missed in the previous video,
  • 3:31 - 3:35
    we have two main dopamine receptors you need to know about. D one receptors activate
  • 3:35 - 3:40
    adenylyl cyclase and re increase and lead to an increase in camp cyclic AMP, and
  • 3:40 - 3:44
    the d two receptors deactivate this, endolyticic
  • 3:44 - 3:50
    and lead to decrease in cyclic AMP. Now when you inhibit the d two dopamine receptors
  • 3:50 - 3:55
    like you do with second generation antipsychotics, what's gonna end up happening
  • 3:55 - 3:59
    is you're gonna have decreased D two act binding,
  • 3:59 - 4:02
    right, because you're inhibiting it, which is gonna lead to
  • 4:02 - 4:07
    an increased D one receptor binding. And eventually
  • 4:07 - 4:10
    oh, bing. Binding. There we go.
  • 4:10 - 4:15
    And that's gonna lead to increase in cyclic AMP.
  • 4:15 - 4:20
    So, therefore, these drugs inhibit d two and act like a d one agonist in
  • 4:20 - 4:24
    a sense. Now, one thing to understand is because you have increased in cyclic AMP,
  • 4:24 - 4:27
    this increase is gonna have a negative feedback on our brain and then it's gonna
  • 4:27 - 4:30
    lead to actually decreasing our dopamine levels.
  • 4:30 - 4:34
    Okay? Overall, you're gonna have a decrease in dopamine.
  • 4:34 - 4:37
    That's very important. Now when it comes to,
  • 4:37 - 4:40
    what's actually happening with first gen antipsychotics,
  • 4:40 - 4:46
    it's the fact that these first gen antipsychotics is are increasing cyclic AMP
  • 4:46 - 4:51
    in our brain. That's what's happened. That's the actual effect. It's not decreasing dopamine levels,
  • 4:51 - 4:57
    it's increasing cyclic AMP by by having, an increase in d one receptor binding.
  • 4:57 - 5:02
    Now, these drugs also tend to block, the serotonin
  • 5:02 - 5:06
    two a receptors as well. And that's very important because often
  • 5:06 - 5:11
    these receptors, the serotonin two a receptors, are hyperstimulated
  • 5:11 - 5:17
    in schizophrenic patients, and hyperstimulation of this receptor
  • 5:17 - 5:22
    leads to increased hallucinations. Right? So you wanna reduce that. And in schizophrenia, that's one
  • 5:22 - 5:25
    of the hallmark signs of schizophrenia is hallucinations, especially auditory hallucinations.
  • 5:26 - 5:30
    So one way you can do it is by giving the second gen antipsychotics
  • 5:30 - 5:33
    And by blocking the HT two A receptor, the serotonin two
  • 5:33 - 5:36
    A receptor, you're gonna decrease the hallucinations
  • 5:36 - 5:41
    that are occurring in the schizophrenic patients. Okay? That's what's gonna end up happening.
  • 5:41 - 5:46
    You're gonna decrease hallucinations. So these are the two main,
  • 5:46 - 5:52
    mechanisms of action. Keep in mind, this really does not occur in first gen antipsychotics.
  • 5:52 - 5:58
    This does. This is definitely what, the d two receptor d two dopamine receptor blockade
  • 5:58 - 6:03
    is what occurs in the first gen. So this is also another, defining feature.
  • 6:03 - 6:07
    Now, ((Lou)), we're gonna talk about all of the adverse side effects of the second gen.
  • 6:07 - 6:11
    There are several adverse side effects and most likely for step one, you're gonna
  • 6:11 - 6:15
    be tested on these side effects. So, the first side effect we're gonna talk about
  • 6:15 - 6:18
    is the metabolic syndrome. Okay.
  • 6:18 - 6:22
    Now, this can happen with any antipsychotic class, but it often happens
  • 6:22 - 6:28
    with the second gen antipsychotics. Okay. This is very important.
  • 6:28 - 6:32
    The second gen antipsychotics are more likely associated with metabolic syndrome. So, what you're
  • 6:32 - 6:37
    gonna see is in these patients, they're gonna present out with weight gain, hyperglycemia,
  • 6:37 - 6:41
    hyperlipidemia and you're gonna see they're getting a little bit fatter since they've been taking
  • 6:41 - 6:45
    their medication. So the way I used to remember this is, by thinking about a
  • 6:45 - 6:49
    fat pine. Right? A pine, because these are the second gen antipsychotics, specifically like
  • 6:49 - 6:52
    clozapine and olanzapine.
  • 6:52 - 6:55
    These are the ones that are gonna cause, increase in the metabolic
  • 6:55 - 6:58
    syndrome. And I just put fat, so that's how I remembered
  • 6:58 - 7:02
    it because these patients have symptoms of just becoming fat. So that's the memory tool
  • 7:02 - 7:05
    I use. That's one side effect, metabolic syndrome.
  • 7:05 - 7:09
    There's a specific drug that you need to know out of all of the second
  • 7:09 - 7:14
    gen antipsychotics and it's not because of what it, what the mechanism is, but it's
  • 7:14 - 7:18
    because of the side effects, the negative side effects of this drug.
  • 7:18 - 7:22
    That drug is clozapine. Clozapine is a very,
  • 7:22 - 7:25
    very strong drug that's used for for schizophrenia,
  • 7:25 - 7:29
    but it has a lot of side effects. And because of these side effects, it's
  • 7:29 - 7:32
    usually not the first line or second line drug.
  • 7:32 - 7:35
    It's gonna be used for treatment resistant schizophrenia
  • 7:35 - 7:39
    and that's how they're gonna phrase it in step one. Okay?
  • 7:39 - 7:43
    So, look out for a patient who's on like a fourth or fifth line drug or a third line
  • 7:43 - 7:47
    drug who's been treated with others anti psychotic
  • 7:47 - 7:51
    drugs, but it hasn't been successful. So now, they've put on this other drug.
  • 7:51 - 7:55
    What ends up happening in these patients who are taking clozapine
  • 7:55 - 7:58
    is that they might present with bone marrow toxicity.
  • 7:58 - 8:02
    So neutropenia and, agranulocytosis
  • 8:02 - 8:06
    can occur in one to two percent of these patients. And that's very important because
  • 8:06 - 8:10
    that is something you will be tested on if you get a question about clozapine.
  • 8:10 - 8:15
    What are the side effects? What can happen? So this is very, very, very important.
  • 8:15 - 8:20
    Clozapine is associated with neutropenia and agranulocytosis.
  • 8:20 - 8:24
    Now, because of this, you need to monitor the neutrophil count weekly.
  • 8:24 - 8:28
    And these patients are also gonna become very susceptible to infection, so you need to
  • 8:28 - 8:31
    make sure if they're running a fever, you gotta make sure nothing's wrong.
  • 8:31 - 8:35
    They're not really getting sick. Now, you also need to monitor their white blood count overall and
  • 8:35 - 8:40
    this is all reversible once the drug is stopped. So that's the first thing.
  • 8:40 - 8:43
    Clozapine, you need to know, it can cause agranulocytosis
  • 8:43 - 8:47
    and they'll present this by asking you what laboratory
  • 8:47 - 8:50
    exam should be done with clozapine.
  • 8:50 - 8:54
    And that's gonna be either a monitor
  • 8:54 - 8:57
    the neutrophil count or white blood count overall.
  • 8:57 - 9:00
    Okay? You're looking for neutropenia and agranulocytosis.
  • 9:00 - 9:04
    Now, you can also have seizures, which are more common compared to bone marrow toxicity,
  • 9:04 - 9:07
    which occur- these seizures are gonna occur two to five percent
  • 9:07 - 9:10
    of the patients and myocarditis or cardiomyopathy.
  • 9:10 - 9:14
    This is also high yield, but in my opinion, if you're gonna try to remember
  • 9:14 - 9:17
    one of these two things, remember this right here, the side
  • 9:17 - 9:20
    effect of the neutropenia and, the a granulocytosis.
  • 9:20 - 9:24
    Myocarditis, cardiomyopathy, and seizures are also something
  • 9:24 - 9:27
    that can happen with clozapine. Just don't forget it.
  • 9:27 - 9:30
    Okay. So that is clozapine.
  • 9:30 - 9:33
    Now there are still more adverse side effects that you need to know about when
  • 9:33 - 9:37
    it comes to the second generation antipsychotics. And the
  • 9:37 - 9:40
    second the main one is gonna be endocrine issues, the next main
  • 9:40 - 9:44
    one. Right? So these, endocrine issues occur because,
  • 9:44 - 9:48
    usually, these drugs are gonna affect the tubulo infundibular,
  • 9:48 - 9:52
    pathway or tubulo infundibular system. And this is one of the main four dopamine pathways
  • 9:52 - 9:58
    in the brain because, normally, dopamine is released by the hypothalamus to to inhibit prolactin.
  • 9:58 - 10:03
    So when you have dopamine, right, so you have dopamine, you're gonna have a decreased
  • 10:03 - 10:08
    prolactin levels. That is normal. Now, what ends up happening is because you have decreased
  • 10:08 - 10:11
    dopamine levels due to blocking the d two
  • 10:11 - 10:16
    receptor, d two dopamine receptor, you're gonna lead to hyperprolactinemia.
  • 10:16 - 10:20
    Why is that? Because you are blocking the d two receptor, you're gonna have more
  • 10:20 - 10:26
    positive d one stimulation, which is gonna lead to increase in cyclic AMP.
  • 10:26 - 10:29
    This increase in cyclic AMP is gonna lead to a decrease in dopamine.
  • 10:29 - 10:36
    And because you are decreasing dopamine, this is all going to lead to hyper prolactin levels.
  • 10:36 - 10:39
    Right? So that is the mechanism that's happening
  • 10:39 - 10:45
    in patients who are taking second gen and first gen antipsychotics. Right? This also happens
  • 10:45 - 10:49
    in first gen. So this is kind of a review from the last lecture. Now when it comes to
  • 10:49 - 10:53
    hyperprolactinemia, in females, you're gonna see, glactorrhea. They're gonna have lactation.
  • 10:53 - 10:57
    In males, you will see gynecomastia
  • 10:57 - 11:02
    occurring. And in both males and females, you'll see you'll have inhibition of GnRH, which
  • 11:02 - 11:07
    leads to oligomenorrhea in females as well as loss of libido and impotence in males.
  • 11:07 - 11:13
    And this is more common in the first gen antipsychotics, but you can see it with the our
  • 11:13 - 11:18
    a, our apines and idones, second generation antipsychotics.
  • 11:18 - 11:21
    Just a little bit of a reminder of the suffixes.
  • 11:21 - 11:25
    Okay. So that is the endo the endocrine issues.
  • 11:25 - 11:28
    Now, there are still some more adverse effects
  • 11:28 - 11:32
    of the second generation antipsychotics that you need to know, and
  • 11:32 - 11:36
    these are gonna be very simple. Okay? These are going to be your anti
  • 11:36 - 11:42
    ham, h a m symptoms.
  • 11:42 - 11:46
    Now these symptoms are gonna be the first one is gonna be the antimuscarinic effects.
  • 11:46 - 11:50
    Okay? The antimuscarinic effects occur because you're blocking
  • 11:50 - 11:53
    the central and peripheral acetylcholine muscarinic receptors.
  • 11:53 - 11:57
    And these antimuscarinic effects are gonna,
  • 11:57 - 12:01
    present with someone having dry mouth, constipation, blurred vision, or just urinary
  • 12:01 - 12:05
    retention. Something that's very common with antimuscarinic
  • 12:05 - 12:09
    or acetylcholine muscarinic receptor blockers. That is something that happens
  • 12:09 - 12:14
    with these drugs. The other thing you could have is orthostatic hypotension, which is all
  • 12:14 - 12:19
    due to blockade, again, of central and peripheral alpha one adrenergic receptors.
  • 12:19 - 12:22
    This can also be accompanied with tachycardia,
  • 12:22 - 12:26
    but this is gonna be more common during initiation
  • 12:26 - 12:30
    and increasing the dose. Once you have initiated and once someone's
  • 12:30 - 12:34
    well along on their treatment with these drugs, it's gonna be perfectly fine. This will
  • 12:34 - 12:38
    go away. Orthostatic hypotension will usually go away.
  • 12:38 - 12:41
    And, the final the final effect is gonna be antihistamine
  • 12:41 - 12:44
    effect, which is gonna be blockade of the central
  • 12:44 - 12:47
    and peripheral histamine receptors and this can lead to sedation.
  • 12:47 - 12:51
    So, like I said, the acronym we use or the memory tool is anti ham.
  • 12:51 - 12:56
    Right? The h stands for the antihistamine, activity.
  • 12:56 - 12:59
    The a stands for the adrenergic antimuscarinic
  • 12:59 - 13:04
    effects. Right? Which Oh, sorry. The alpha one adrenergic effects, which are going to block
  • 13:04 - 13:08
    the which are going to lead to orthostatic hypotension.
  • 13:08 - 13:12
    Okay. So the alpha one blockade. Right. Let's just put that here. And then finally,
  • 13:12 - 13:16
    the m is going to stand for the muscarinic or the acetylcholine muscarinic receptor blockade.
  • 13:16 - 13:21
    Okay. So that's what happens. So the anti ham. This can also happen
  • 13:21 - 13:25
    in first generation antipsychotics.
  • 13:25 - 13:31
    Okay? More so in the low potency first generation antipsychotics.
  • 13:31 - 13:37
    This is very similar to those. Now, I wish we were done, but unfortunately,
  • 13:37 - 13:42
    we still have one more very important adverse side effect that you need to be
  • 13:42 - 13:45
    aware of. And we've already discussed this, so we're not gonna go too deep into it.
  • 13:45 - 13:50
    If you guys wanna watch our previous episode about the the first generation antipsychotics,
  • 13:50 - 13:54
    I highly recommend you do so to get a more detailed understanding of this.
  • 13:54 - 13:57
    But, the last or the second to last
  • 13:57 - 14:02
    adverse side effect that can that can occur is gonna be the neuroleptic
  • 14:02 - 14:06
    malignant syndrome, NMS. Now you may be saying, why am I bringing this up here?
  • 14:06 - 14:11
    It usually occurs in first gen antipsychotics. You're right. It usually does occur in the
  • 14:11 - 14:17
    first gen antipsychotics, specifically the high potency first gen antipsychotics,
  • 14:17 - 14:23
    but you definitely still need to know that it can happen in the second generation antipsychotics.
  • 14:23 - 14:28
    It's less common, but it can happen. And this is still gonna be caused by
  • 14:28 - 14:33
    blocking any, dopamine receptor. So anything that blocks dopamine
  • 14:33 - 14:36
    receptors that has dopamine blocking agents in them,
  • 14:36 - 14:40
    along with a genetic predisposition,
  • 14:40 - 14:43
    it can lead to NMS, the neuroleptic
  • 14:43 - 14:48
    malignant syndrome. So just a reminder, this syndrome can happen at any time and the
  • 14:48 - 14:51
    timeline does not matter. Unlike the extrapyramidal
  • 14:51 - 14:56
    symptoms like, you know, acute dystonia, which happens hours to days after starting the drug
  • 14:56 - 15:02
    and, you know, the, the akathisia, the parkinsonism,
  • 15:02 - 15:06
    and atardive dyskinesia, it's gonna happen a little bit later.
  • 15:06 - 15:11
    NMS doesn't usually follow any timeline, so it can happen at any point. So this
  • 15:11 - 15:15
    is a neurologic emergency and the symptoms are
  • 15:15 - 15:21
    gonna include myoglobin myoglobinuria, rhabdomyolysis,
  • 15:21 - 15:25
    and elevated enzymes. The vitals are gonna be very unstable,
  • 15:25 - 15:29
    okay, because they're going through a lot of stuff at this moment. They're also gonna
  • 15:29 - 15:33
    have fever and encephalopathy contributing to the unstable vitals.
  • 15:33 - 15:37
    And also, they're gonna have muscle rigidity, the lead pipe rigidity. And this is a
  • 15:37 - 15:43
    hallmark indication that someone is going through a neuroleptic malignant
  • 15:43 - 15:46
    syndrome. So I'm gonna write hallmark next to it as well as high yield as
  • 15:46 - 15:50
    fuck for you guys so you don't forget this is very important. Now this muscle
  • 15:50 - 15:55
    rigidity, this lead pipe rigidity, this is a very important phrase because this is gonna
  • 15:55 - 15:59
    be a giveaway for step one, is also gonna lead to all of these issues.
  • 15:59 - 16:03
    The myoglobin urea, the rhabdomyolysis, and the elevated
  • 16:03 - 16:06
    c k levels are all gonna be due to the lead pipe
  • 16:06 - 16:10
    rigidity in the muscles because the the the muscle cells are gonna end up bursting
  • 16:10 - 16:14
    due to that rigidity. Okay? Now that is one of the stuff one of the
  • 16:14 - 16:17
    things that can happen. And the last adverse effect that you need to be aware
  • 16:17 - 16:21
    of for second gen antipsychotics is gonna be QT prolongation.
  • 16:21 - 16:25
    Now, this can lead to Tresard du Plants and cardiac
  • 16:25 - 16:30
    death. So you can see right here, we have a little image of these undulating,
  • 16:30 - 16:35
    QRS complexes that aren't normal. Not QRS. Sorry. The, cardiac
  • 16:35 - 16:40
    arrhythmias right here. They're not normal. It's kinda in this wave like waveform.
  • 16:40 - 16:45
    So these are called Tresades de Pointes and, eventually, this will lead to cardiac death
  • 16:45 - 16:49
    if it's not taken care of and these patients aren't stabilized.
  • 16:49 - 16:53
    Okay. So this is definitely all the adverse effects you need to know. This is
  • 16:53 - 16:56
    very high yield. And, again, just like the first gen antipsychotics,
  • 16:56 - 17:00
    second gen antipsychotics are also pretty dense. Not as dense, but they're still pretty dense.
  • 17:00 - 17:04
    So I highly recommend you guys, you know, go over this lecture, go over this
  • 17:04 - 17:08
    content a couple times so you know this stuff inside and out and you have
  • 17:08 - 17:12
    a good understanding of what's happening. Now, when it comes to the second gen antipsychotics,
  • 17:12 - 17:17
    there's some fast facts you definitely need to know. Okay. So I would personally take
  • 17:17 - 17:21
    a screenshot of this this slide or just take a photo of it, keep it
  • 17:21 - 17:26
    in your phone so you can constantly look at it and remind yourself what's happening.
  • 17:26 - 17:29
    Olanzapine and clozapine
  • 17:29 - 17:33
    are more likely to cause weight gain and metabolic syndrome than any of these other
  • 17:33 - 17:38
    drugs. Okay. That's very, very important. And on the opposite end, aripiprazole
  • 17:38 - 17:44
    and ziprazodone are least likely to cause weight gain. So if you have a patient who's underweight
  • 17:44 - 17:48
    and schizophrenic, you might wanna give these patients olanzapine
  • 17:48 - 17:52
    and clozapine. Right? And remember, with clozapine,
  • 17:52 - 17:55
    you need to watch out for their,
  • 17:55 - 17:59
    neutrophil count. You have to make sure it's very, very strong.
  • 17:59 - 18:02
    And if you have someone who's overweight or, you know, a little bit on the heavier side
  • 18:02 - 18:07
    with schizophrenia, you might wanna give them aripiprazole and zaprazodone.
  • 18:07 - 18:12
    The next drug, risperidone, is most likely to cause the hyperprolactinemia
  • 18:12 - 18:16
    and the endocrine issues. So, with risperidone, you wanna watch out for a decreased libido
  • 18:16 - 18:20
    in males and impotence. You wanna wanna watch out for gynecomastia
  • 18:20 - 18:25
    as well as in males. And in females, you wanna watch out for oligomenorrhea
  • 18:25 - 18:28
    and, you know, lactation, galactorrhea.
  • 18:28 - 18:33
    Aripiprazole is gonna be the least sedating, but you have the highest risk for akathisia in
  • 18:33 - 18:37
    this drug because this is also a partial agonist
  • 18:37 - 18:41
    of the D2 receptor. So akathisia can occur,
  • 18:41 - 18:44
    in these drugs. This has a higher risk. And then quetapine
  • 18:44 - 18:47
    is the most sedating drug. The way
  • 18:47 - 18:52
    I always remembered it is that people are quiet with quietepine. I know it's like,
  • 18:52 - 18:55
    you know, misspelled. The e and the I are flipped, but that's how I remembered
  • 18:55 - 18:59
    quietepine as being the most sedating. The olanzapine,
  • 18:59 - 19:02
    this o, I always thought of someone with a really fat stomach.
  • 19:02 - 19:08
    Right, so that looked like o for me. So that was olanzapine.
  • 19:08 - 19:12
    So I I always remembered someone with a really fat circular or o like stomach,
  • 19:12 - 19:15
    who takes olanzapine, they'll become really fat. Now,
  • 19:15 - 19:18
    when it comes to the last drug,
  • 19:18 - 19:25
    Clozapine. Clozapine has the strongest anti muscarinic effects as well. So keep that in mind.
  • 19:25 - 19:32
    Clozapine is very, very, anti muscarinic. So you're gonna have the anti ham effects like
  • 19:32 - 19:38
    the sedation, the ortho psych hypertension. But when it comes to anti muscarinic effects, you'll see
  • 19:38 - 19:41
    dry mouth, constipation and blurred vision.
  • 19:41 - 19:45
    Specifically, these effects can occur with clozapine.
  • 19:45 - 19:48
    Now, clozapine also don't forget the agranulocytosis.
  • 19:48 - 19:51
    I didn't write that, but I was just gonna write here.
  • 19:51 - 19:57
    Agranulocytosis and they can you can also have
  • 19:57 - 20:02
    seizures plus
  • 20:02 - 20:06
    you can have cardiomyopathies.
  • 20:06 - 20:10
    There we go. So don't forget all
  • 20:10 - 20:14
    of the side effects for clozapine.
  • 20:14 - 20:18
    In my opinion, that's probably the most confusing one to remember. Now, with that being
  • 20:18 - 20:21
    said, we are done with the second gen antipsychotics.
  • 20:21 - 20:25
    Thank you so much for listening and
  • 20:25 - 20:28
    watching to this lecture and, I hope this was very helpful. Now, if you guys
  • 20:28 - 20:32
    don't know, don't forget to like, comment, and subscribe. And if you wanna watch these
  • 20:32 - 20:37
    videos, if you wanna listen to these videos on the go, you can follow us on our podcast.
  • 20:37 - 20:40
    And we're posting all of these lectures on our podcast, so you can listen to
  • 20:40 - 20:43
    these lectures on the go. So just search Mad Medicine on any podcast service provider
  • 20:43 - 20:47
    and it will be able to pop up. Thank you.
Title:
2nd Generation Antipsychotics (Psychiatry) (Pharmacology) - USMLE Step 1
Description:

more » « less
Video Language:
English
Duration:
20:47

English subtitles

Revisions